{"content":"<li class=\"n-box-item date-title\" data-end=\"1546318799\" data-start=\"1546232400\" data-txt=\"Monday, December 23, 2019\">Monday, December 31, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3419830\" data-ts=\"1546295624\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HASI\" target=\"_blank\">HASI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419830-hasi-vips-hty-and-imh-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HASI, VIPS, HTY and IMH among notable after hour movers</a></h4><ul><li><b>Top Gainers: </b><a href='https://seekingalpha.com/symbol/HASI' title='Hannon Armstrong Sustainable Infrastructure Capital'>HASI</a> <font color=\"green\">+6.82%</font>. <a href='https://seekingalpha.com/symbol/VIPS' title='Vipshop Holdings'>VIPS</a> <font color=\"green\">+4.76%</font>. <a href='https://seekingalpha.com/symbol/WTI' title='W&T Offshore, Inc.'>WTI</a> <font color=\"green\">+4.37%</font>. <a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a> <font color=\"green\">+2.66%</font>. <a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a> <font color=\"green\">+2.65%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/HTY' title='John Hancock Tax-Advantaged Global Shareholder Yield Fund'>HTY</a> <font color=\"red\">-8.13%</font>. <a href='https://seekingalpha.com/symbol/IMH' title='Impac Mortgage Holdings, Inc.'>IMH</a> <font color=\"red\">-7.41%</font>. <a href='https://seekingalpha.com/symbol/TEF' title='Telefonica S.A.'>TEF</a> <font color=\"red\">-5.44%</font>. <a href='https://seekingalpha.com/symbol/MFGP' title='Micro Focus International plc ADR'>MFGP</a> <font color=\"red\">-5.17%</font>. <a href='https://seekingalpha.com/symbol/SKY' title='Skyline Champion Corp'>SKY</a> <font color=\"red\">-5.11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419830\" data-linked=\"HASI, VIPS, HTY and IMH among notable after hour movers\" data-tweet=\"$HASI $HASI $VIPS - HASI, VIPS, HTY and IMH among notable after hour movers https://seekingalpha.com/news/3419830-hasi-vips-hty-and-imh-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3419830-hasi-vips-hty-and-imh-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419825\" data-ts=\"1546292474\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTI\" target=\"_blank\">PTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419825-proteostasis-up-8-after-hours-on-successful-phase-1-study-of-ptiminus-428\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Proteostasis up 8% after hours on successful Phase 1 study of PTI-428</a></h4><ul><li>Proteostasis Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a>) is up <font color=\"green\">8%</font> after hours on the heels of its Phase 1 clinical trial evaluating PTI-428 in cystic fibrosis patients on background Kalydeco (ivacaftor) therapy.</li><li>The company says the study met the primary (safety and tolerability) and secondary endpoints (pharmacokinetics) but it did not perform exploratory analyses on other measures (efficacy) due to the small number of enrollees.</li><li>Related ticker: (NASDAQ:<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3419825\" data-linked=\"Proteostasis up 8% after hours on successful Phase 1 study of PTI-428\" data-tweet=\"$PTI $PTI $VRTX - Proteostasis up 8% after hours on successful Phase 1 study of PTI-428 https://seekingalpha.com/news/3419825-proteostasis-up-8-after-hours-on-successful-phase-1-study-of-ptiminus-428?source=tweet\" data-url=\"https://seekingalpha.com/news/3419825-proteostasis-up-8-after-hours-on-successful-phase-1-study-of-ptiminus-428\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419820\" data-ts=\"1546291745\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHFS\" target=\"_blank\">CHFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419820-chf-solutions-files-for-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CHF Solutions files for equity offering</a></h4><ul><li>CHF Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/CHFS' title='CHF Solutions, Inc.'>CHFS</a>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1506492/000114036118046154/s002610x1_s1.htm\" target=\"_blank\">preliminary prospectus</a> for a public offering of Class A and Class B Units.</li><li>Each Class A Unit will consist of one common share and one warrant to purchase one common share.</li><li>Each Class B Unit will consist of one share of Series G Convertible Preferred Stock valued at $1,000 and warrants to purchase the same number of converted common shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419820\" data-linked=\"CHF Solutions files for equity offering\" data-tweet=\"$CHFS - CHF Solutions files for equity offering https://seekingalpha.com/news/3419820-chf-solutions-files-for-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3419820-chf-solutions-files-for-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419818\" data-ts=\"1546291424\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVAX\" target=\"_blank\">NVAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419818-novavax-files-for-100m-stock-offering-shares-down-4-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novavax files for $100M stock offering; shares down 4% after hours</a></h4><ul><li>Novavax (NASDAQ:<a href='https://seekingalpha.com/symbol/NVAX' title='Novavax, Inc.'>NVAX</a>) slips <font color=\"red\">4%</font> after hours in response to its <a href=\"https://www.sec.gov/Archives/edgar/data/1000694/000114420418066754/tv510077-424b5.htm\" target=\"_blank\">planned sale</a> of up to $100M of its common stock through sales agent B. Riley FBR who will earn a 2% commission for its efforts.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419818\" data-linked=\"Novavax files for $100M stock offering; shares down 4% after hours\" data-tweet=\"$NVAX - Novavax files for $100M stock offering; shares down 4% after hours https://seekingalpha.com/news/3419818-novavax-files-for-100m-stock-offering-shares-down-4-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3419818-novavax-files-for-100m-stock-offering-shares-down-4-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419807\" data-ts=\"1546290574\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADMP\" target=\"_blank\">ADMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419807-adamis-pharma-submits-u-s-marketing-application-for-naloxone-prefilled-syringe-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adamis Pharma submits U.S. marketing application for naloxone prefilled syringe; shares up 1% after hours</a></h4><ul><li>Adamis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corp.'>ADMP</a>) is up <font color=\"green\">1%</font> after hours following its <a href=\"https://seekingalpha.com/pr/17367899-adamis-pharmaceuticals-submits-new-drug-application-fda-naloxone-pre-filled-syringe\" target=\"_blank\">announcement </a>that it has filed a U.S. marketing application seeking approval for a single-dose prefilled syringe formulation of opioid overdose agent naloxone.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419807\" data-linked=\"Adamis Pharma submits U.S. marketing application for naloxone prefilled syringe; shares up 1% after hours\" data-tweet=\"$ADMP - Adamis Pharma submits U.S. marketing application for naloxone prefilled syringe; shares up 1% after hours https://seekingalpha.com/news/3419807-adamis-pharma-submits-u-s-marketing-application-for-naloxone-prefilled-syringe-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3419807-adamis-pharma-submits-u-s-marketing-application-for-naloxone-prefilled-syringe-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419799\" data-ts=\"1546288873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMXC\" target=\"_blank\">CMXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419799-cell-medx-secures-250k-credit-linek-shares-down-27\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cell MedX secures $250K credit linek; shares down 27%</a></h4><ul><li>Ultra-thinly traded Cell MedX Corp. (<a href='https://seekingalpha.com/symbol/CMXC' title='Cell MedX Corp.'>OTCQB:CMXC</a> <font color=\"red\">-26.7%</font>) is down, albeit on turnover of only 1,000 shares, on the heels of its <a href=\"https://seekingalpha.com/pr/17367881-cell-medx-corp-enters-credit-line-agreement-issues-warrants\" target=\"_blank\">announcement </a>that it has established an unsecured $250K line of credit with top shareholder Richard Jeffs. $100K was advanced to the company on December 20.</li><li>Borrowings will carry a 6% interest rate. Mr. Jeffs has received three-year warrants to purchase up to 5M common shares at $0.05 per share contingent on the total borrowed (he received warrants to purchase 2M common shares based on the $100K advancement).</li></ul><div class=\"tiny-share-widget\" data-id=\"3419799\" data-linked=\"Cell MedX secures $250K credit linek; shares down 27%\" data-tweet=\"$CMXC - Cell MedX secures $250K credit linek; shares down 27% https://seekingalpha.com/news/3419799-cell-medx-secures-250k-credit-linek-shares-down-27?source=tweet\" data-url=\"https://seekingalpha.com/news/3419799-cell-medx-secures-250k-credit-linek-shares-down-27\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419797\" data-ts=\"1546287907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLTH\" target=\"_blank\">HLTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419797-nobilis-health-lands-new-in-network-contract-shares-up-44\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nobilis Health lands new in-network contract; shares up 44%</a></h4><ul><li>Thinly traded nano cap Nobilis Health (<a href='https://seekingalpha.com/symbol/HLTH' title='Nobilis Health Corp.'>HLTH</a> <font color=\"green\">+44%</font>) is up on more than double normal volume on the heels of its <a href=\"https://seekingalpha.com/pr/17367862-nobilis-health-announces-new-network-contract-plano-surgical-hospital\" target=\"_blank\">announcement </a>that it has inked an in-network contract with Plano Surgical Hospital that will commence tomorrow, January 1, 2019.</li><li>The facility is now in-network with three of the largest commercial payors in the U.S.</li><li>The company says the contract increases its in-network status in Texas to ~60%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419797\" data-linked=\"Nobilis Health lands new in-network contract; shares up 44%\" data-tweet=\"$HLTH - Nobilis Health lands new in-network contract; shares up 44% https://seekingalpha.com/news/3419797-nobilis-health-lands-new-in-network-contract-shares-up-44?source=tweet\" data-url=\"https://seekingalpha.com/news/3419797-nobilis-health-lands-new-in-network-contract-shares-up-44\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419796\" data-ts=\"1546287523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APHA\" target=\"_blank\">APHA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419796-green-growth-re-emphasizes-intent-to-acquire-aphria\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Green Growth re-emphasizes intent to acquire Aphria</a></h4><ul><li>Green Growth Brands <a href=\"https://seekingalpha.com/pr/17367882-green-growth-brands-reaffirms-commitment-takeover-aphria-inc\" target=\"_blank\">reaffirms </a>its commitment to acquire pot producer Aphria (<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a> <font color=\"red\">-6.5%</font>) for C$11 per share. If consummated, Aphria shareholders will own 60% of the combined company while Green Growth shareholders will own ~34%. Subscribers to its C$300M financing will own ~6%.</li><li>Aphria's board has been cool to the unsolicited offer, however. Green Growth is undeterred, willing to work with Aphria to \"find ways\" to enhance value for both companies, adding that it is confident that it can secure the C$300M financing that appears contingent on a C$7/share valuation.</li><li>Green Growth says over 10% of Aphria's shareholders have indicated their support for the transaction.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419796\" data-linked=\"Green Growth re-emphasizes intent to acquire Aphria\" data-tweet=\"$APHA - Green Growth re-emphasizes intent to acquire Aphria https://seekingalpha.com/news/3419796-green-growth-re-emphasizes-intent-to-acquire-aphria?source=tweet\" data-url=\"https://seekingalpha.com/news/3419796-green-growth-re-emphasizes-intent-to-acquire-aphria\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>78&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419792\" data-ts=\"1546285796\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMCSA\" target=\"_blank\">CMCSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419792-comcast-settles-fcc-dispute\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comcast settles FCC dispute</a></h4><ul><li>Comcast's (NASDAQ:<a href='https://seekingalpha.com/symbol/CMCSA' title='Comcast Corporation'>CMCSA</a>) NBC/Telemundo <a href=\"https://www.fcc.gov/document/fcc-adopts-consent-decree-nbcuniversal\" target=\"_blank\">will pay $495K</a> to settle with the FCC on alleged violations of the Children's Television Act of 1990.</li><li>The consent decree relates to some stations preempting required children's programing with sports.</li><li>Comcast shares are<font color=\"red\"> down 1.6%</font> to $33.62.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419792\" data-linked=\"Comcast settles FCC dispute\" data-tweet=\"$CMCSA - Comcast settles FCC dispute https://seekingalpha.com/news/3419792-comcast-settles-fcc-dispute?source=tweet\" data-url=\"https://seekingalpha.com/news/3419792-comcast-settles-fcc-dispute\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:49 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419791\" data-ts=\"1546285573\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLF\" target=\"_blank\">SLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419791-sun-life-raised-to-buy-argus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sun Life raised to buy by Argus</a></h4><ul><li>Sun Life Financial (NYSE:<a href='https://seekingalpha.com/symbol/SLF' title='Sun Life Financial, Inc.'>SLF</a>)<font color=\"green\"> gains 1.9% </font>after Argus analyst Steve Delaney <a href=\"https://thefly.com/landingPageNews.php?id=2842121&amp;headline=STAR;SLF;APDN;DYNT;FNFV;RMAX;STC;AFL;PRI-Fly-Intel-Todays-top-analyst-calls-on-Wall-Street\" target=\"_blank\">upgrades</a> the stock to buy from hold, saying the stock's valuation is more attractive after it fell 18% since his last report.</li><li>Notes consistent, strong earnings; above peer average ROE; some small acquisitions should bolster earnings.</li><li>Price target: $39.</li><li>Source: The Fly.</li><li><a href=\"https://seekingalpha.com/symbol/SLF/earnings/analyst_ratings\" target=\"_blank\">Analyst ratings</a>: 8 buys; 7 holds; 0 underperform/sell.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3418272-sun-life-financial-acquire-majority-stake-bentall-greenoak\" target=\"_blank\">Sun Life Financial to acquire majority stake in Bentall GreenOak</a> (Dec. 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3419791\" data-linked=\"Sun Life raised to buy by Argus\" data-tweet=\"$SLF - Sun Life raised to buy by Argus https://seekingalpha.com/news/3419791-sun-life-raised-to-buy-argus?source=tweet\" data-url=\"https://seekingalpha.com/news/3419791-sun-life-raised-to-buy-argus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419790\" data-ts=\"1546285148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTLA\" target=\"_blank\">PTLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419790-trading-halt-on-portola-pharmaceuticals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trading halt on Portola Pharmaceuticals</a></h4><ul> <li>Portola Pharmaceuticals (<a href='https://seekingalpha.com/symbol/PTLA' title='Portola Pharmaceuticals'>PTLA</a> <font color='red'>-3.2%</font>) is under a Nasdaq trading halt with news pending out from the company.</li> <li>Bloomberg reports that an Andexxa-related decision is due out from the FDA today.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3419790\" data-linked=\"Trading halt on Portola Pharmaceuticals\" data-tweet=\"$PTLA - Trading halt on Portola Pharmaceuticals https://seekingalpha.com/news/3419790-trading-halt-on-portola-pharmaceuticals?source=tweet\" data-url=\"https://seekingalpha.com/news/3419790-trading-halt-on-portola-pharmaceuticals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419783\" data-ts=\"1546282748\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LEU\" target=\"_blank\">LEU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419783-centrus-energy-and-bristow-group-among-energy-materials-gainers-american-midstream-partners\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Centrus Energy and Bristow Group among Energy/Materials gainers; American Midstream Partners and ION Geophysical among losers</a></h4><ul><li><b>Gainers: </b>Centrus Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/LEU' title='Centrus Energy Corp.'>LEU</a>) <font color=\"green\">+13%</font>. Bristow Group (NYSE:<a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a>) <font color=\"green\">+12%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"green\">+12%</font>. Ossen Innovation (NASDAQ:<a href='https://seekingalpha.com/symbol/OSN' title='Ossen Innovation Co., Ltd.'>OSN</a>) <font color=\"green\">+10%</font>. SilverCrest Metals (NYSEMKT:<a href='https://seekingalpha.com/symbol/SILV' title='SilverCrest Metals, Inc.'>SILV</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>American Midstream Partners (NYSE:<a href='https://seekingalpha.com/symbol/AMID' title='American Midstream Partners, LP'>AMID</a>) <font color=\"red\">-27%</font>. ION Geophysical (NYSE:<a href='https://seekingalpha.com/symbol/IO' title='ION Geophysical Corporation'>IO</a>) <font color=\"red\">-9%</font>. Emerge Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/EMES' title='Emerge Energy Services LP'>EMES</a>) <font color=\"red\">-9%</font>. Pioneer Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a>) <font color=\"red\">-9%</font>. Piedmont Lithium (NASDAQ:<a href='https://seekingalpha.com/symbol/PLL' title='Piedmont Lithium Limited'>PLL</a>) <font color=\"red\">-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419783\" data-linked=\"Centrus Energy and Bristow Group among Energy/Materials gainers; American Midstream Partners and ION Geophysical among losers\" data-tweet=\"$LEU $LEU $BRS - Centrus Energy and Bristow Group among Energy/Materials gainers; American Midstream Partners and ION Geophysical among losers https://seekingalpha.com/news/3419783-centrus-energy-and-bristow-group-among-energy-materials-gainers-american-midstream-partners?source=tweet\" data-url=\"https://seekingalpha.com/news/3419783-centrus-energy-and-bristow-group-among-energy-materials-gainers-american-midstream-partners\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419779\" data-ts=\"1546281210\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/F\" target=\"_blank\">F</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419779-headwinds-seen-for-detroit-three-in-2019\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Headwinds seen for Detroit Three in 2019</a></h4><ul> <li>The auto industry has had a rough ride in 2018 and the focus on the last trading day has been on numbers coming out later this week on December U.S. sales.</li><li>Bank of America Merrill Lynch expects total U.S. auto sales to fall off 1% in December. Ford's (<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a> <font color='red'>-1.7%</font>) sales are forecast to drop 7.5% during the month, while Fiat Chrysler Automobiles (<a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a> <font color='red'>-0.5%</font>) is seen churning up a 15% gain for the month on a strong performance for the Jeep Compass, Jeep Wrangler and Jeep Cherokee models. General Motors (<a href='https://seekingalpha.com/symbol/GM' title='General Motors Company'>GM</a> <font color='red'>-1.1%</font>) is anticipated to post a flat Y/Y sales month as the automaker sticks with a disciplined approach to pricing.</li><li>All three Detroit automakers are down sharply for the year, led by Ford's 39% tumble, and the view for 2019 isn't particularly rosy either.</li>  <li>BAML's outlook for 2019: \"We believe there were a variety of factors that won't repeat and propped up sales, such as replacement demand from natural disasters in 2H:17 and tax reform. As such, we continue to believe that the US cycle has entered the early innings of a downturn. Furthermore, a number of headwinds are increasingly intensifying, including price/mix, raw materials, and interest rates, which could drive further sales declines into next year.\"</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3419779\" data-linked=\"Headwinds seen for Detroit Three in 2019\" data-tweet=\"$F $F $FCAU - Headwinds seen for Detroit Three in 2019 https://seekingalpha.com/news/3419779-headwinds-seen-for-detroit-three-in-2019?source=tweet\" data-url=\"https://seekingalpha.com/news/3419779-headwinds-seen-for-detroit-three-in-2019\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:33 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>82&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419774\" data-ts=\"1546279079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KFS\" target=\"_blank\">KFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419774-cnat-amid-pirs-and-apvo-among-notable-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CNAT, AMID, PIRS and APVO among notable midday movers</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KFS' title='Kingsway Financial Services Inc'>KFS</a> <font color=\"green\">+27%</font>. <a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color=\"green\">+23%</font>. <a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a> <font color=\"green\">+22%</font>. <a href='https://seekingalpha.com/symbol/CADC' title='China Advanced Construction Materials Group, Inc.'>CADC</a> <font color=\"green\">+20%</font>. <a href='https://seekingalpha.com/symbol/IPIC' title='iPic Entertainment Inc.'>IPIC</a> <font color=\"green\">+20%</font>. <a href='https://seekingalpha.com/symbol/AXSM' title='Axsome Therapeutics'>AXSM</a> <font color=\"green\">+18%</font>. <a href='https://seekingalpha.com/symbol/LPCN' title='Lipocine Inc.'>LPCN</a> <font color=\"green\">+19%</font>. <a href='https://seekingalpha.com/symbol/MGEN' title='Miragen Therapeutics, Inc.'>MGEN</a> <font color=\"green\">+17%</font>. <a href='https://seekingalpha.com/symbol/SHOS' title='Sears Hometown and Outlet Stores, Inc.'>SHOS</a> <font color=\"green\">+17%</font>. <a href='https://seekingalpha.com/symbol/EQ' title='Equillium'>EQ</a> <font color=\"green\">+17%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NFEC' title='NF Energy Saving Corp.'>NFEC</a> <font color=\"red\">-29%</font>. <a href='https://seekingalpha.com/symbol/AMID' title='American Midstream Partners, LP'>AMID</a> <font color=\"red\">-28%</font>. <a href='https://seekingalpha.com/symbol/APVO' title='Aptevo Therapeutics Inc.'>APVO</a> <font color=\"red\">-14%</font>. <a href='https://seekingalpha.com/symbol/ESTR' title='Estre Ambiental, Inc.'>ESTR</a> <font color=\"red\">-14%</font>. <a href='https://seekingalpha.com/symbol/NDRA' title='Endra Life Sciences Inc'>NDRA</a> <font color=\"red\">-13%</font>. <a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a> <font color=\"red\">-13%</font>. <a href='https://seekingalpha.com/symbol/PIRS' title='Pieris Pharmaceuticals, Inc.'>PIRS</a> <font color=\"red\">-13%</font>. <a href='https://seekingalpha.com/symbol/ANY' title='Sphere 3D Corp.'>ANY</a> <font color=\"red\">-13%</font>. <a href='https://seekingalpha.com/symbol/ASTC' title='Astrotech Corporation'>ASTC</a> <font color=\"red\">-12%</font>. <a href='https://seekingalpha.com/symbol/PLXP' title='PLx Pharma'>PLXP</a> <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419774\" data-linked=\"CNAT, AMID, PIRS and APVO among notable midday movers\" data-tweet=\"$KFS $KFS $CNAT - CNAT, AMID, PIRS and APVO among notable midday movers https://seekingalpha.com/news/3419774-cnat-amid-pirs-and-apvo-among-notable-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3419774-cnat-amid-pirs-and-apvo-among-notable-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419773\" data-ts=\"1546279044\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KFS\" target=\"_blank\">KFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419773-kingsway-financial-services-leads-financial-gainers-elbit-imaging-and-camping-world-holdings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kingsway Financial Services leads financial gainers; Elbit Imaging and Camping World Holdings among losers</a></h4><ul><li><b>Gainers: </b>Kingsway Financial Services (NYSE:<a href='https://seekingalpha.com/symbol/KFS' title='Kingsway Financial Services Inc'>KFS</a>) <font color=\"green\">+23%</font>. Landmark Infrastructure Partners (NASDAQ:<a href='https://seekingalpha.com/symbol/LMRK' title='Landmark Infrastructure Partners LP'>LMRK</a>) <font color=\"green\">+11%</font>. Conifer Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CNFR' title='Conifer Holdings'>CNFR</a>) <font color=\"green\">+7%</font>. Broadway Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/BYFC' title='Broadway Financial Corporation'>BYFC</a>) <font color=\"green\">+6%</font>. X Financial (NYSE:<a href='https://seekingalpha.com/symbol/XYF' title='X Financial'>XYF</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Carver Bancorp (NASDAQ:<a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a>) <font color=\"red\">-13%</font>. Elbit Imaging (NASDAQ:<a href='https://seekingalpha.com/symbol/EMITF' title='Elbit Imaging Ltd.'>EMITF</a>) <font color=\"red\">-11%</font>. Camping World Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CWH' title='Camping World Holdings'>CWH</a>) <font color=\"red\">-8%</font>. China Rapid Finance (NYSE:<a href='https://seekingalpha.com/symbol/XRF' title='China Rapid Finance'>XRF</a>) <font color=\"red\">-8%</font>. Equus Total Return (NYSE:<a href='https://seekingalpha.com/symbol/EQS' title='Equus Total Return'>EQS</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419773\" data-linked=\"Kingsway Financial Services leads financial gainers; Elbit Imaging and Camping World Holdings among losers\" data-tweet=\"$KFS $KFS $LMRK - Kingsway Financial Services leads financial gainers; Elbit Imaging and Camping World Holdings among losers https://seekingalpha.com/news/3419773-kingsway-financial-services-leads-financial-gainers-elbit-imaging-and-camping-world-holdings?source=tweet\" data-url=\"https://seekingalpha.com/news/3419773-kingsway-financial-services-leads-financial-gainers-elbit-imaging-and-camping-world-holdings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419772\" data-ts=\"1546278077\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARLZQ\" target=\"_blank\">ARLZQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419772-aralez-pharma-completes-sale-of-vimovo-royalties-and-canadian-ops-shares-up-50\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aralez Pharma completes sale of Vimovo royalties and Canadian ops; shares up 50%</a></h4><ul><li>Aralez Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ARLZQ' title='ARALEZ PHARMS INC'>OTCPK:ARLZQ</a> <font color=\"green\">+50%</font>) has <a href=\"https://seekingalpha.com/pr/17367828-aralez-pharmaceuticals-completes-sale-vimovo-royalties-canadian-operations-nuvo\" target=\"_blank\">completed </a>the sale of its VIMOVO royalties and Canadian operations to Nuvo Pharmaceuticals for $110M.</li><li>The sale of its TOPROL-XL franchise to Deerfield Management for $130M remains in process.</li><li>Aralez filed for Chapter 11 bankruptcy in August 2018.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3391368-nuvo-pharmaceuticals-acquire-commercial-products-infrastructure-aralez-pharmaceuticals\" target=\"_blank\">Nuvo Pharmaceuticals to acquire commercial products and infrastructure from Aralez Pharmaceuticals</a> (Sept. 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3419772\" data-linked=\"Aralez Pharma completes sale of Vimovo royalties and Canadian ops; shares up 50%\" data-tweet=\"$ARLZQ - Aralez Pharma completes sale of Vimovo royalties and Canadian ops; shares up 50% https://seekingalpha.com/news/3419772-aralez-pharma-completes-sale-of-vimovo-royalties-and-canadian-ops-shares-up-50?source=tweet\" data-url=\"https://seekingalpha.com/news/3419772-aralez-pharma-completes-sale-of-vimovo-royalties-and-canadian-ops-shares-up-50\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419769\" data-ts=\"1546277203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CWH\" target=\"_blank\">CWH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419769-camping-world-sell-off-extends\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Camping World sell-off extends</a></h4><ul> <li>Investors continue to bid down Camping World (<a href='https://seekingalpha.com/symbol/CWH' title='Camping World Holdings'>CWH</a> <font color='red'>-8.1%</font>) after the company disclosed the exit of President Roger Nuttall late on Friday.</li> <li>Volume on CWH has already topped the normal daily average of 1.07M shares.</li> <li>Shares of Camping World are now down 42% over the last 90 days, despite signs during December of some inventory stabilization in the RV industry.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3419769\" data-linked=\"Camping World sell-off extends\" data-tweet=\"$CWH - Camping World sell-off extends https://seekingalpha.com/news/3419769-camping-world-sell-off-extends?source=tweet\" data-url=\"https://seekingalpha.com/news/3419769-camping-world-sell-off-extends\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419767\" data-ts=\"1546275649\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FUV\" target=\"_blank\">FUV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419767-arcimoto-leads-consumer-gainers-energous-and-b-and-g-food-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arcimoto leads consumer gainers; Energous and B&amp;G Food among losers</a></h4><ul><li><b>Gainers: </b>Arcimoto (NASDAQ:<a href='https://seekingalpha.com/symbol/FUV' title='Arcimoto, Inc.'>FUV</a>) <font color=\"green\">+13%</font>. Kewaunee Scientific (NASDAQ:<a href='https://seekingalpha.com/symbol/KEQU' title='Kewaunee Scientific Corporation'>KEQU</a>) <font color=\"green\">+10%</font>. Xcel Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/XELB' title='Xcel Brands, Inc.'>XELB</a>) <font color=\"green\">+8%</font>. Youngevity International (NASDAQ:<a href='https://seekingalpha.com/symbol/YGYI' title='Youngevity International, Inc.'>YGYI</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>Pingtan Marine Enterprise (NASDAQ:<a href='https://seekingalpha.com/symbol/PME' title='Pingtan Marine Enterprise Ltd.'>PME</a>) <font color=\"red\">-12%</font>. Energous (NASDAQ:<a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a>) <font color=\"red\">-10%</font>. B&amp;G Foods (NYSE:<a href='https://seekingalpha.com/symbol/BGS' title='B&G Foods, Inc.'>BGS</a>) <font color=\"red\">-6%</font>. P. H. Glatfelter (NYSE:<a href='https://seekingalpha.com/symbol/GLT' title='Glatfelter'>GLT</a>) <font color=\"red\">-6%</font>. DAVIDsTEA (NASDAQ:<a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDs TEA'>DTEA</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419767\" data-linked=\"Arcimoto leads consumer gainers; Energous and B&amp;G Food among losers\" data-tweet=\"$FUV $FUV $KEQU - Arcimoto leads consumer gainers; Energous and B&amp;G Food among losers https://seekingalpha.com/news/3419767-arcimoto-leads-consumer-gainers-energous-and-b-and-g-food-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3419767-arcimoto-leads-consumer-gainers-energous-and-b-and-g-food-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419765\" data-ts=\"1546275590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICPT\" target=\"_blank\">ICPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419765-cnbc-article-highlights-35b-market-opportunity-of-nash-drugs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CNBC article highlights $35B market opportunity of NASH drugs</a></h4><ul><li>CNBC <a href=\"https://www.cnbc.com/2018/12/21/the-35-billion-race-for-a-cure-for-a-liver-disease-that-affects-millions.html\" target=\"_blank\">reports </a>that nonalcoholic steatohepatitis or NASH is \"next big thing\" for drug makers, a potential market of $35B or more if pharma/biotech firms can successfully navigate the regulatory process, a task none has accomplished to date.</li><li>NASH, an obesity-related complication, is believed to affect about 30M Americans. Its precursor, nonalcoholic fatty liver disease, affects ~89M Americans, including people in their 20s and 30s.</li><li>The FDA has approved only one NASH candidate thus far, Intercept Pharmaceuticals' (<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a> <font color=\"green\">+4.5%</font>) Ocaliva (obeticholic acid), for a rare autoimmune disorder called primary biliary cholangitis &#40;PBC&#41; that can lead to cirrhosis. The agency OK'd the drug in May 2016.</li><li>Several companies have potential therapies in Phase 3 development. Most candidates are in Phase 2.</li><li>NASH-related tickers: (<a href='https://seekingalpha.com/symbol/MDGL' title='Madrigal Pharmaceuticals, Inc.'>MDGL</a> <font color=\"green\">+3.5%</font>)(<a href='https://seekingalpha.com/symbol/VKTX' title='Viking Therapeutics'>VKTX</a> <font color=\"green\">+0.5%</font>)(<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color=\"green\">+0.5%</font>)(<a href='https://seekingalpha.com/symbol/CBAY' title='CymaBay Therapeutics'>CBAY</a> <font color=\"red\">-0.5%</font>)(<a href='https://seekingalpha.com/symbol/ENTA' title='Enanta Pharmaceuticals, Inc.'>ENTA</a> <font color=\"red\">-1.1%</font>)(<a href='https://seekingalpha.com/symbol/RGLS' title='Regulus Therapeutics'>RGLS</a> <font color=\"red\">-0.9%</font>)(<a href='https://seekingalpha.com/symbol/INNT' title='Innovate Biopharmaceuticals, Inc.'>INNT</a> <font color=\"red\">-4.9%</font>)(<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a> <font color=\"green\">+18.8%</font>)(<a href='https://seekingalpha.com/symbol/WVE' title='Wave Life Sciences'>WVE</a> <font color=\"green\">+2.1%</font>)(<a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color=\"green\">+4.1%</font>)(<a href='https://seekingalpha.com/symbol/GNFTF' title='Genfit'>OTCPK:GNFTF</a> <font color=\"green\">+1.2%</font>)(<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a> <font color=\"green\">+2.7%</font>)(<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color=\"green\">+4.5%</font>)(<a href='https://seekingalpha.com/symbol/ASMB' title='Assembly Biosciences, Inc.'>ASMB</a> <font color=\"green\">+0.4%</font>)(<a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite Biopharma Ltd'>CANF</a> <font color=\"green\">+1.9%</font>)(<a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a> <font color=\"red\">-1.8%</font>)(<a href='https://seekingalpha.com/symbol/GLMD' title='Galmed Pharmaceuticals Ltd.'>GLMD</a> <font color=\"red\">-4.5%</font>)(<a href='https://seekingalpha.com/symbol/IMRN' title='Immuron Limited'>IMRN</a>)(<a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics'>GEMP</a> <font color=\"green\">+4.1%</font>)(<a href='https://seekingalpha.com/symbol/ORMP' title='Oramed Pharmaceuticals Inc.'>ORMP</a> <font color=\"red\">-1.9%</font>)(<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color=\"red\">-0.3%</font>)(<a href='https://seekingalpha.com/symbol/VBLT' title='VBL Therapeutics'>VBLT</a> <font color=\"green\">+3.9%</font>)(<a href='https://seekingalpha.com/symbol/SHPG' title='Shire PLC'>SHPG</a> <font color=\"green\">+0.6%</font>)(<a href='https://seekingalpha.com/symbol/DRNA' title='Dicerna Pharmaceuticals, Inc.'>DRNA</a> <font color=\"green\">+2.3%</font>)(<a href='https://seekingalpha.com/symbol/HZNP' title='Horizon Pharma plc'>HZNP</a> <font color=\"red\">-0.1%</font>)(<a href='https://seekingalpha.com/symbol/ARCT' title='Arcturus Therapeutics Ltd.'>ARCT</a> <font color=\"green\">+10.9%</font>)(<a href='https://seekingalpha.com/symbol/RETA' title='Reata Pharmaceuticals'>RETA</a> <font color=\"green\">+1.1%</font>)(<a href='https://seekingalpha.com/symbol/FGEN' title='FibroGen'>FGEN</a> <font color=\"green\">+1.6%</font>)(<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color=\"green\">+0.9%</font>)(<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color=\"green\">+0.4%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3419765\" data-linked=\"CNBC article highlights $35B market opportunity of NASH drugs\" data-tweet=\"$ICPT $ICPT $MDGL - CNBC article highlights $35B market opportunity of NASH drugs https://seekingalpha.com/news/3419765-cnbc-article-highlights-35b-market-opportunity-of-nash-drugs?source=tweet\" data-url=\"https://seekingalpha.com/news/3419765-cnbc-article-highlights-35b-market-opportunity-of-nash-drugs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>60&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419763\" data-ts=\"1546274629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKE\" target=\"_blank\">NKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419763-digging-through-retail-stocks-bin\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digging through the retail stocks bin</a></h4><ul> <li>Analysts continue to find some value picks after the sell-off across the retail sector. The latest is Piper Jaffray retail analyst Erinn Murphy, who singles out lifestyle brand companies as her <a href=\"https://www.barrons.com/articles/retail-stock-picks-2019-51546269933\" target=\"_blank\">top</a> retail sector picks for 2019.</li> <li>Murphy's list of favorites from the retail bin includes Nike (<a href='https://seekingalpha.com/symbol/NKE' title='Nike Inc.'>NKE</a> <font color='green'>+0.3%</font>), Under Armour (<a href='https://seekingalpha.com/symbol/UA' title='Under Armour, Inc. Class C'>UA</a>, <a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a>), Ulta Beauty (<a href='https://seekingalpha.com/symbol/ULTA' title='Ulta Beauty, Inc.'>ULTA</a> <font color='green'>+1.3%</font>), Crocs (<a href='https://seekingalpha.com/symbol/CROX' title='Crocs, Inc.'>CROX</a> <font color='red'>-2%</font>) and Funko (<a href='https://seekingalpha.com/symbol/FNKO' title='Funko, Inc.'>FNKO</a> <font color='red'>-2.4%</font>).</li> <li>On a broader look at the sector, various reads on retail sales have come in strong over the last few weeks, but investors have been slow to shake off trade jitters and concerns of an economic slowdown for major names such as Target (<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a> <font color='green'>+1.2%</font>), Walmart (<a href='https://seekingalpha.com/symbol/WMT' title='Walmart Inc.'>WMT</a> <font color='green'>+0.5%</font>) and Costco (<a href='https://seekingalpha.com/symbol/COST' title='Costco Wholesale Corporation'>COST</a> <font color='red'>-0.1%</font>).</li><li>Retail stocks trading with a single digit forward price-to-earnings ratio include Michaels Companies (<a href='https://seekingalpha.com/symbol/MIK' title='The Michaels Companies'>MIK</a> <font color='red'>-0.1%</font>), Party City (<a href='https://seekingalpha.com/symbol/PRTY' title='Party City Holdco, Inc.'>PRTY</a> <font color='green'>+0.2%</font>), J. Jill (<a href='https://seekingalpha.com/symbol/JILL' title='J. Jill Group, Inc.'>JILL</a> <font color='green'>+1.9%</font>), Bed Bath &amp; Beyond (<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a> <font color='red'>-3.4%</font>), Macy's (<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a> <font color='red'>-0.9%</font>) and L Brands (<a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a> <font color='red'>-0.5%</font>).</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLY' title='Consumer Discretionary Select Sector SPDR ETF'>XLY</a>, <a href='https://seekingalpha.com/symbol/XRT' title='SPDR S&P Retail ETF'>XRT</a>, <a href='https://seekingalpha.com/symbol/VCR' title='Vanguard Consumer Discretionary ETF'>VCR</a>, <a href='https://seekingalpha.com/symbol/RTH' title='VanEck Vectors Retail ETF'>RTH</a>, <a href='https://seekingalpha.com/symbol/RETL' title='Direxion Daily Retail Bull 3x Shares ETF'>RETL</a>, <a href='https://seekingalpha.com/symbol/FDIS' title='Fidelity MSCI Consumer Discretionary Index ETF'>FDIS</a>, <a href='https://seekingalpha.com/symbol/IYK' title='iShares U.S. Consumer Goods ETF'>IYK</a>, <a href='https://seekingalpha.com/symbol/FXD' title='First Trust Consumer Discretionary AlphaDEX ETF'>FXD</a>, <a href='https://seekingalpha.com/symbol/IYC' title='iShares U.S. Consumer Services ETF'>IYC</a>, <a href='https://seekingalpha.com/symbol/EMTY' title='ProShares Decline of the Retail Store ETF'>EMTY</a>, <a href='https://seekingalpha.com/symbol/SCC' title='ProShares UltraShort Consumer Services ETF'>SCC</a>, <a href='https://seekingalpha.com/symbol/RCD' title='Invesco S&P Equal Weight Consumer Discretionary ETF'>RCD</a>, <a href='https://seekingalpha.com/symbol/UCC' title='ProShares Ultra Consumer Services ETF'>UCC</a>, <a href='https://seekingalpha.com/symbol/PMR' title='Invesco Dynamic Retail Portfolio ETF'>PMR</a>, <a href='https://seekingalpha.com/symbol/UGE' title='ProShares Ultra Consumer Goods ETF'>UGE</a>, <a href='https://seekingalpha.com/symbol/SZK' title='ProShares UltraShort Consumer Goods ETF'>SZK</a>, <a href='https://seekingalpha.com/symbol/FTXD' title='First Trust Nasdaq Retail ETF'>FTXD</a>, <a href='https://seekingalpha.com/symbol/JHMC' title='John Hancock Multifactor Consumer Discretionary ETF'>JHMC</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3419763\" data-linked=\"Digging through the retail stocks bin\" data-tweet=\"$NKE $NKE $UA - Digging through the retail stocks bin https://seekingalpha.com/news/3419763-digging-through-retail-stocks-bin?source=tweet\" data-url=\"https://seekingalpha.com/news/3419763-digging-through-retail-stocks-bin\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419756\" data-ts=\"1546272234\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLTH\" target=\"_blank\">HLTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419756-nobilis-adds-to-rally-up-26\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nobilis adds to rally, up 26%</a></h4><ul><li>Thinly traded nano cap Nobilis Health (<a href='https://seekingalpha.com/symbol/HLTH' title='Nobilis Health Corp.'>HLTH</a> <font color=\"green\">+25.8%</font>) is up on below-average volume. Shares have more than doubled since last Wednesday.</li><li>On Thursday, December 27, the company announced the appointment of new CEO James Springfield. The company will host a <a href=\"https://seekingalpha.com/pr/17366818-nobilis-health-announces-appointment-new-ceo-conference-call\" target=\"_blank\">conference call</a> on Wednesday, January 2, 2019, at 8:00 am ET to introduce him to investors.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419756\" data-linked=\"Nobilis adds to rally, up 26%\" data-tweet=\"$HLTH - Nobilis adds to rally, up 26% https://seekingalpha.com/news/3419756-nobilis-adds-to-rally-up-26?source=tweet\" data-url=\"https://seekingalpha.com/news/3419756-nobilis-adds-to-rally-up-26\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419755\" data-ts=\"1546272132\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTVT\" target=\"_blank\">VTVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419755-conatus-pharmaceuticals-and-axsome-therapeutics-among-healthcare-gainers-aphria-and-aptevo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Conatus Pharmaceuticals and Axsome Therapeutics among healthcare gainers; Aphria and Aptevo Therapeutics among losers</a></h4><ul><li><b>Gainers: </b>vTv Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VTVT' title='vTv Therapeutics'>VTVT</a>) <font color=\"green\">+35%</font>. Conatus Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CNAT' title='Conatus Pharmaceuticals'>CNAT</a>) <font color=\"green\">+18%</font>. Axsome Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AXSM' title='Axsome Therapeutics'>AXSM</a>) <font color=\"green\">+17%</font>. Miragen Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MGEN' title='Miragen Therapeutics, Inc.'>MGEN</a>) <font color=\"green\">+15%</font>. Marker Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MRKR' title='Marker Therapeutics Inc'>MRKR</a>) <font color=\"green\">+15%</font>.</li><li><b>Losers: </b>Aptevo Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/APVO' title='Aptevo Therapeutics Inc.'>APVO</a>) <font color=\"red\">-11%</font>. OptiNose (NASDAQ:<a href='https://seekingalpha.com/symbol/OPTN' title='OptiNose, Inc.'>OPTN</a>) <font color=\"red\">-11%</font>. ENDRA Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/NDRA' title='Endra Life Sciences Inc'>NDRA</a>) <font color=\"red\">-11%</font>. BioLife Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/BLFS' title='BioLife Solutions, Inc.'>BLFS</a>) <font color=\"red\">-9%</font>. Aphria (NYSE:<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a>) <font color=\"red\">-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419755\" data-linked=\"Conatus Pharmaceuticals and Axsome Therapeutics among healthcare gainers; Aphria and Aptevo Therapeutics among losers\" data-tweet=\"$VTVT $VTVT $CNAT - Conatus Pharmaceuticals and Axsome Therapeutics among healthcare gainers; Aphria and Aptevo Therapeutics among losers https://seekingalpha.com/news/3419755-conatus-pharmaceuticals-and-axsome-therapeutics-among-healthcare-gainers-aphria-and-aptevo?source=tweet\" data-url=\"https://seekingalpha.com/news/3419755-conatus-pharmaceuticals-and-axsome-therapeutics-among-healthcare-gainers-aphria-and-aptevo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419748\" data-ts=\"1546270937\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419748-tesla-still-plenty-of-inventory\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla still with plenty of inventory?</a></h4><ul><li><a href=\"https://electrek.co/2018/12/31/tesla-model-3-inventory-us/\" target=\"_blank\">According to Elektrek</a>, Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) still has more than 3K Model 3s in U.S. inventory as of Sunday.</li><li>That would be at odds with the company's aim to liquidate all inventory by year-end. While some cars will surely be delivered today, more than 3K seems unlikely.</li><li>Shares have reversed an early gain, now <font color=\"red\">down 0.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419748\" data-linked=\"Tesla still with plenty of inventory?\" data-tweet=\"$TSLA - Tesla still with plenty of inventory? https://seekingalpha.com/news/3419748-tesla-still-plenty-of-inventory?source=tweet\" data-url=\"https://seekingalpha.com/news/3419748-tesla-still-plenty-of-inventory\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>200&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419724\" data-ts=\"1546270368\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SQ\" target=\"_blank\">SQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419724-fintech-etfs-outperform-s-and-p-in-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fintech ETFs outperform the S&amp;P in 2018</a></h4><ul><li>Though hardly a stellar performance, global X FinTech Thematic ETF (NASDAQ:<a href='https://seekingalpha.com/symbol/FINX' title='Global X FinTech Thematic ETF'>FINX</a>) edged up 0.5% during the year and ETFMG Prime Mobile Payments ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/IPAY' title='ETFMG Prime Mobile Payments ETF'>IPAY</a>) -0.1% in the past year, both outperforming the SPDR S&amp;P 500 ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/SPY' title='SPDR S&P 500 Trust ETF'>SPY</a>), which fell 5.4% in the past year.</li><li>The two fintech ETFs look even better when compared with the financial sector overall. The Financial Select Sector SPDR ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a>) fell 14% in the past year.</li><li>Among individual fintech names, Square (NYSE:<a href='https://seekingalpha.com/symbol/SQ' title='Square, Inc.'>SQ</a>) stood out as the most impressive gainer, surging 61% during the year. Others that climbed during the year--Intuit (NASDAQ:<a href='https://seekingalpha.com/symbol/INTU' title='Intuit Inc.'>INTU</a>) +24%, PayPal (NASDAQ:<a href='https://seekingalpha.com/symbol/PYPL' title='PayPal Holdings, Inc.'>PYPL</a>) +13%, Fiserv (NASDAQ:<a href='https://seekingalpha.com/symbol/FISV' title='Fiserv, Inc.'>FISV</a>) +11%.</li><li>The big difference between FINX and IPAY is that IPAY holds big credit card companies--American Express (NYSE:<a href='https://seekingalpha.com/symbol/AXP' title='American Express Company'>AXP</a>), Mastercard (NYSE:<a href='https://seekingalpha.com/symbol/MA' title='Mastercard, Inc.'>MA</a>), Visa (NYSE:<a href='https://seekingalpha.com/symbol/V' title='Visa Inc.'>V</a>), and Discover Financial (NYSE:<a href='https://seekingalpha.com/symbol/DFS' title='Discover Financial Services'>DFS</a>), some of which weighed down the ETF.</li><li>DFS fell 24% during the year and AXP slid 4.9%, while MA rose 23% and V increased 15%.</li><li>Meanwhile, FINX focuses more on the tech part of fintech, including Intuit, SS&amp;C Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SSNC' title='SS&C Technologies Holdings, Inc.'>SSNC</a>) +11%, and Guidewire Software (NYSE:<a href='https://seekingalpha.com/symbol/GWRE' title='Guidewire Software, Inc.'>GWRE</a>) +6.9%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3417846-payment-stocks-recession-resistance-may-outperform-2019-rbc\" target=\"_blank\">Payment stocks with `recession resistance' may outperform in 2019: RBC</a> (Dec. 18)</li></ul><div class=\"tiny-share-widget\" data-id=\"3419724\" data-linked=\"Fintech ETFs outperform the S&amp;P in 2018\" data-tweet=\"$SQ $FINX $IPAY - Fintech ETFs outperform the S&amp;P in 2018 https://seekingalpha.com/news/3419724-fintech-etfs-outperform-s-and-p-in-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3419724-fintech-etfs-outperform-s-and-p-in-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419744\" data-ts=\"1546269765\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NNDM\" target=\"_blank\">NNDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419744-nano-dimension-up-24\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nano Dimension up 24%</a></h4><ul><li>Thinly traded nano cap Nano Dimension Ltd. (<a href='https://seekingalpha.com/symbol/NNDM' title='Nano Dimension Ltd ADR'>NNDM</a> <font color=\"green\">+23.5%</font>) is up on almost triple normal volume, albeit on turnover of only 241K shares.</li><li>Earlier this month, the additive electronics provider filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1643303/000121390018016984/fwp120618_nanodimension.htm\" target=\"_blank\">prospectus supplement</a> for a $25M equity offering.</li><li>Last week it <a href=\"https://www.sec.gov/Archives/edgar/data/1643303/000121390018017855/f6k122618ex99-1_nano.htm\" target=\"_blank\">announced </a>DragonFly Pro reseller deals in Belgium, the Netherlands, Luxemburg and Israel.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419744\" data-linked=\"Nano Dimension up 24%\" data-tweet=\"$NNDM - Nano Dimension up 24% https://seekingalpha.com/news/3419744-nano-dimension-up-24?source=tweet\" data-url=\"https://seekingalpha.com/news/3419744-nano-dimension-up-24\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419742\" data-ts=\"1546268724\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FUV\" target=\"_blank\">FUV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419742-arcimoto-adds-to-capital-raise-stoked-up-move-shares-ahead-17\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arcimoto adds to capital raise-stoked up move, shares ahead 17%</a></h4><ul><li>Thinly traded nano cap Arcimoto (<a href='https://seekingalpha.com/symbol/FUV' title='Arcimoto, Inc.'>FUV</a> <font color=\"green\">+16.6%</font>) is up on average volume, adding to Friday's <font color=\"green\">19%</font> move in response to its <a href=\"https://seekingalpha.com/pr/17367146-arcimoto-inc-secures-4_5-million-financing-initiate-production-ultra-efficient-electric\" target=\"_blank\">$4.5M capital raise</a>.</li><li>Specifically, the company sold 500K shares of common stock at $3 per share and issued a $3M one-year secured senior note bearing 10% interest plus a warrant to purchase ~943K common shares at $3.50 per share.</li><li>Net proceeds will fund the manufacture, assembly and delivery of its first retail Fun Utility Vehicles.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419742\" data-linked=\"Arcimoto adds to capital raise-stoked up move, shares ahead 17%\" data-tweet=\"$FUV - Arcimoto adds to capital raise-stoked up move, shares ahead 17% https://seekingalpha.com/news/3419742-arcimoto-adds-to-capital-raise-stoked-up-move-shares-ahead-17?source=tweet\" data-url=\"https://seekingalpha.com/news/3419742-arcimoto-adds-to-capital-raise-stoked-up-move-shares-ahead-17\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419741\" data-ts=\"1546268670\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EROS\" target=\"_blank\">EROS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419741-eros-announces-syndication-deals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eros announces syndication deals</a></h4><ul><li>Eros (NYSE:<a href='https://seekingalpha.com/symbol/EROS' title='Eros International Plc'>EROS</a>) announces executing several long-term television syndication deals with TV networks around the world for its over 60 catalogue films.</li><li>The TV networks include Viacom \u2013 Colors in India, SABC in South Africa, E Vision in the UAE, and Tanzania TV. </li><li>Eros shares are <font color=\"red\">down 1.6%</font> to $8.18.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419741\" data-linked=\"Eros announces syndication deals\" data-tweet=\"$EROS - Eros announces syndication deals https://seekingalpha.com/news/3419741-eros-announces-syndication-deals?source=tweet\" data-url=\"https://seekingalpha.com/news/3419741-eros-announces-syndication-deals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419737\" data-ts=\"1546268189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFET\" target=\"_blank\">SFET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419737-safe-t-up-26-on-order-from-israeli-beverage-maker\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Safe-T up 26% on order from Israeli beverage maker</a></h4><ul><li>Thinly traded nano cap Safe-T (<a href='https://seekingalpha.com/symbol/SFET' title='Safe-T Group Ltd'>SFET</a> <font color=\"green\">+25.5%</font>) is up up on a 22x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/17367657-safe-t-receives-order-largest-israeli-beverage-company-sda-sde-solutions\" target=\"_blank\">announced </a>software order from the largest beverage maker in Israel. The ordered system is an extension of the SDE and SDA integration solution that the beverage company currently uses.</li><li>Safe-T says the order includes licenses for \"thousands\" of users.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419737\" data-linked=\"Safe-T up 26% on order from Israeli beverage maker\" data-tweet=\"$SFET - Safe-T up 26% on order from Israeli beverage maker https://seekingalpha.com/news/3419737-safe-t-up-26-on-order-from-israeli-beverage-maker?source=tweet\" data-url=\"https://seekingalpha.com/news/3419737-safe-t-up-26-on-order-from-israeli-beverage-maker\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419733\" data-ts=\"1546267800\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRS\" target=\"_blank\">AMRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419733-amyris-inks-nutritional-product-royalty-deal-chinas-xinfu-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amyris inks nutritional product royalty deal with China&#39;s Xinfu; shares up 2%</a></h4><ul><li>Amyris (<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a> <font color=\"green\">+2.3%</font>) is up on average volume in early trade on the heels of its <a href=\"https://seekingalpha.com/pr/17367749-amyris-announces-signing-nutritional-product-royalty-agreement\" target=\"_blank\">announcement </a>of a long-term contract with Xinfu of China for a \"significant initial payment and a long-term minimum annual share\" of an existing nutritional product royalty agreement.</li><li>The transaction enables Amyris to monetize a portion of the royalty stream to better manage volatility while maintaining access to future upside in the payment structure.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419733\" data-linked=\"Amyris inks nutritional product royalty deal with China&#39;s Xinfu; shares up 2%\" data-tweet=\"$AMRS - Amyris inks nutritional product royalty deal with China&#39;s Xinfu; shares up 2% https://seekingalpha.com/news/3419733-amyris-inks-nutritional-product-royalty-deal-chinas-xinfu-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3419733-amyris-inks-nutritional-product-royalty-deal-chinas-xinfu-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>48&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419730\" data-ts=\"1546266994\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCHYY\" target=\"_blank\">SCHYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419730-sands-china-denies-mobile-ban-in-mainland-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sands China denies mobile ban in Mainland China</a></h4><ul> <li>Sands China (<a href='https://seekingalpha.com/symbol/SCHYY' title='Sands China Ltd ADR'>OTCPK:SCHYY</a>, <a href='https://seekingalpha.com/symbol/SCHYF' title='Sands China Ltd'>OTCPK:SCHYF</a>, <a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a>) responds to local reports that its mobile app is being banned in Mainland China.</li> <li>\"Sands China confirms that all our official mobile apps continue to be accessible and function normally from within China. Our applications and websites comply strictly with Chinese rules and regulations,\" reads a company <a href=\"http://www.macaubusiness.com/macau-sands-china-denies-that-chinese-govt-banned-its-application-on-the-mainland/\" target=\"_blank\">statement</a>.</li> <li>Sands China closed <font color=\"green\">up 2.3%</font> in Hong Kong today, while parent Las Vegas Sands is <font color=\"green\">up 1.1%</font> in the U.S.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3419730\" data-linked=\"Sands China denies mobile ban in Mainland China\" data-tweet=\"$SCHYY $SCHYY $SCHYF - Sands China denies mobile ban in Mainland China https://seekingalpha.com/news/3419730-sands-china-denies-mobile-ban-in-mainland-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3419730-sands-china-denies-mobile-ban-in-mainland-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419723\" data-ts=\"1546266556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPST\" target=\"_blank\">CPST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419723-h-c-wainwright-sees-big-upside-for-capstone\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">H.C. Wainwright sees big upside for Capstone</a></h4><ul><li>There are \"several catalysts in the story that support a healthy outlook for the company,\" H.C. Wainwright's Amit Dayal wrote in a research note, <a href=\"https://www.smarteranalyst.com/brief/capstone-turbine-corp-cpst-receives-a-buy-from-h-c-wainwright/\" target=\"_blank\">maintainng</a> a Buy rating on Capstone Turbine (NASDAQ:<a href='https://seekingalpha.com/symbol/CPST' title='Capstone Turbine Corporation'>CPST</a>) shares, with a price target of $2.</li><li>Those include the company's Distributor Support System with $1.1M in funding, demand for lower cost remanufactured systems and its expansion in emerging markets.</li><li>CPST <font color=\"green\">+5%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3419723\" data-linked=\"H.C. Wainwright sees big upside for Capstone\" data-tweet=\"$CPST - H.C. Wainwright sees big upside for Capstone https://seekingalpha.com/news/3419723-h-c-wainwright-sees-big-upside-for-capstone?source=tweet\" data-url=\"https://seekingalpha.com/news/3419723-h-c-wainwright-sees-big-upside-for-capstone\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419720\" data-ts=\"1546265685\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACST\" target=\"_blank\">ACST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419720-acasti-up-4-premarket-on-advancement-of-capre-studies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Acasti up 4% premarket on advancement of CaPre studies</a></h4><ul><li>Nano cap Acasti Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ACST' title='Acasti Pharma, Inc.'>ACST</a>) is up <font color=\"green\">4%</font> premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17367708-acasti-pharma-announces-trilogy-phase-3-trials-capre-patients-severe-hypertriglyceridemia-now\" target=\"_blank\">announcement</a> that patient randomization in its two Phase 3 clinical trials evaluating CaPre (omega-3 phospholipid) in patients with elevated triglycerides in the blood (hypertriglyceridemia) is now over 65% with more than 100 participants completing the six-month treatment plan.</li><li>On another note, it has received a notice from Nasdaq that its stock price no longer meets its $1 minimum bid price listing requirement so investors should expect a reverse stock split in the near future.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419720\" data-linked=\"Acasti up 4% premarket on advancement of CaPre studies\" data-tweet=\"$ACST - Acasti up 4% premarket on advancement of CaPre studies https://seekingalpha.com/news/3419720-acasti-up-4-premarket-on-advancement-of-capre-studies?source=tweet\" data-url=\"https://seekingalpha.com/news/3419720-acasti-up-4-premarket-on-advancement-of-capre-studies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419719\" data-ts=\"1546265334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMID\" target=\"_blank\">AMID</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419719-apha-and-trxc-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">APHA and TRXC among premarket losers</a></h4><ul><li>American Midstream Partners (NYSE:<a href='https://seekingalpha.com/symbol/AMID' title='American Midstream Partners, LP'>AMID</a>) <font color=\"red\">-21%</font>.</li><li>Cool Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings Inc.'>AWSM</a>) <font color=\"red\">-7%</font>.</li><li>Aphria (NYSE:<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a>) <font color=\"red\">-7%</font> on <a href=\"https://seekingalpha.com/news/3419692-aphria-7-percent-premarket-questions-green-growth-bid\" target=\"_blank\">questions</a> with Green Growth bid.</li><li>TransEnterix (NYSEMKT:<a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a>) <font color=\"red\">-6%</font> on $75M <a href=\"https://seekingalpha.com/news/3419710-transenterix-9-percent-premarket-75m-stock-sales-deal\" target=\"_blank\">stock sales</a> deal.</li><li>Sphere 3D (NASDAQ:<a href='https://seekingalpha.com/symbol/ANY' title='Sphere 3D Corp.'>ANY</a>) <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3419719\" data-linked=\"APHA and TRXC among premarket losers\" data-tweet=\"$AMID $AMID $AWSM - APHA and TRXC among premarket losers https://seekingalpha.com/news/3419719-apha-and-trxc-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3419719-apha-and-trxc-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419717\" data-ts=\"1546265093\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SESN\" target=\"_blank\">SESN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419717-sfet-sesn-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SFET, SESN among premarket gainers</a></h4><ul><li>Safe-T (NASDAQ:<a href='https://seekingalpha.com/symbol/SFET' title='Safe-T Group Ltd Sponsored ADR'>SFET</a>) <font color=\"green\">+47%</font> on <a href=\"https://seekingalpha.com/pr/17367657-safe-t-receives-order-largest-israeli-beverage-company-sda-sde-solutions\" target=\"_blank\">receiving an order</a> from the largest Israeli beverage company.</li><li>Sesen Bio (NASDAQ:<a href='https://seekingalpha.com/symbol/SESN' title='Sesen Bio, Inc.'>SESN</a>) <font color=\"green\">+9%</font>.</li><li>Canada Goose Holdings (NYSE:<a href='https://seekingalpha.com/symbol/GOOS' title='Canada Goose Holdings'>GOOS</a>) <font color=\"green\">+8%</font> <a href=\"https://seekingalpha.com/news/3419666-canada-goose-plus-6-percent-beijing-store-dazzles\" target=\"_blank\">after</a> Beijing store dazzles.</li><li>Adamis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ADMP' title='Adamis Pharmaceuticals Corp.'>ADMP</a>) <font color=\"green\">+8%</font> <a href=\"https://seekingalpha.com/news/3419670-adamis-pharma-files-u-s-marketing-application-fast-dissolving-sublingual-tadalafil-tablet-ed\" target=\"_blank\">files</a> U.S. marketing application for fast-dissolving sublingual tadalafil tablet for ED.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419717\" data-linked=\"SFET, SESN among premarket gainers\" data-tweet=\"$SESN $SFET $SESN - SFET, SESN among premarket gainers https://seekingalpha.com/news/3419717-sfet-sesn-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3419717-sfet-sesn-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419716\" data-ts=\"1546265059\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPCN\" target=\"_blank\">LPCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419716-lipocine-up-6-premarket-on-tlando-phlebotomy-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lipocine up 6% premarket on Tlando phlebotomy study</a></h4><ul><li>Thinly traded nano cap Lipocine (NASDAQ:<a href='https://seekingalpha.com/symbol/LPCN' title='Lipocine Inc.'>LPCN</a>) is up <font color=\"green\">6%</font> premarket, albeit on only 200 shares, in response to the results from a <a href=\"https://seekingalpha.com/pr/17367711-lipocine-announces-successful-ex-vivo-conversion-assessment-tlando\" target=\"_blank\">phlebotomy study</a> assessing the potential <em>ex vivo</em> conversion of testosterone undecanoate (TLANDO) to testosterone in serum blood collection tubes.</li><li>The results showed no significant conversion in samples collected per the Phase 3 protocol.</li><li>The company conducted the study as part of its response to the FDA's CRL issued in May.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3354426-fda-rejects-lipocines-application-trt-med-tlando-shares-38-percent-premarket\" target=\"_blank\">FDA rejects Lipocine's application for TRT med Tlando; shares down 38% premarket</a> (May 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3419716\" data-linked=\"Lipocine up 6% premarket on Tlando phlebotomy study\" data-tweet=\"$LPCN - Lipocine up 6% premarket on Tlando phlebotomy study https://seekingalpha.com/news/3419716-lipocine-up-6-premarket-on-tlando-phlebotomy-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3419716-lipocine-up-6-premarket-on-tlando-phlebotomy-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419713\" data-ts=\"1546264647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419713-bird-box-lift-for-netflix\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bird Box lift for Netflix</a></h4><ul> <li>Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) is <font color=\"green\">up 1.85%</font> in premarket trading after Friday's late afternoon tweet on huge <a href=\"https://seekingalpha.com/news/3419621-netflix-45m-streamed-bird-box-week\" target=\"_blank\">streaming numbers</a> for Bird Box.</li> <li>While the company is taking on some criticism for its <a href=\"https://www.theverge.com/2018/12/30/18161741/bird-box-netflix-45-million-accounts-statistics-views\" target=\"_blank\">limited</a> approach to releasing viewership data and historical discrepancies with Nielsen numbers, there is no question that Bird Box is a trending topic on various social media platforms.</li> <li>Some digging by <em>The Verge</em> indicates that at least 45M people watched at least 70% of the supernatural thriller. That number could be significantly higher considering friends and family may have watched the show together. <em>The Hollywood Reporter's</em> Daniel Feinberg isn't quite so positive. \"I\u2019m fairly sure Bird Box is a phenomenon of some sort, but without verifiable data or comparative data for context, a Netflix-affiliated Twitter feed coming down from on-high with suspiciously specific (and yet entirely vague) data is the epitome of nonsense,\" he <a href=\"https://twitter.com/TheFienPrint/status/1078753905096323073\" target=\"_blank\">tweeted</a>.</li><li>Shares of Netflix are up 33% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3419713\" data-linked=\"Bird Box lift for Netflix\" data-tweet=\"$NFLX - Bird Box lift for Netflix https://seekingalpha.com/news/3419713-bird-box-lift-for-netflix?source=tweet\" data-url=\"https://seekingalpha.com/news/3419713-bird-box-lift-for-netflix\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419712\" data-ts=\"1546264459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRN\" target=\"_blank\">AMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419712-amarin-up-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amarin up 2% premarket</a></h4><ul><li>Amarin (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation PLC'>AMRN</a>) is up <font color=\"green\">2%</font> premarket on light volume, giving longs some hope that the recent selloff has run its course. Shares have retreated <font color=\"red\">43%</font> since touching $23.34 on November 6.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419712\" data-linked=\"Amarin up 2% premarket\" data-tweet=\"$AMRN - Amarin up 2% premarket https://seekingalpha.com/news/3419712-amarin-up-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3419712-amarin-up-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419710\" data-ts=\"1546264103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRXC\" target=\"_blank\">TRXC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419710-transenterix-down-9-premarket-on-75m-stock-sales-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TransEnterix down 9% premarket on $75M stock sales deal</a></h4><ul><li>TransEnterix (NYSEMKT:<a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a>) is off <font color=\"red\">9%</font> premarket on light volume on the heels of its $75M at-the-market stock sales <a href=\"https://www.sec.gov/Archives/edgar/data/876378/000119312518361006/d675151d424b5.htm\" target=\"_blank\">agreement </a>with Stifel.</li><li>Stifel will earn a 3% commission for its efforts.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419710\" data-linked=\"TransEnterix down 9% premarket on $75M stock sales deal\" data-tweet=\"$TRXC - TransEnterix down 9% premarket on $75M stock sales deal https://seekingalpha.com/news/3419710-transenterix-down-9-premarket-on-75m-stock-sales-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3419710-transenterix-down-9-premarket-on-75m-stock-sales-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419709\" data-ts=\"1546263984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPOT\" target=\"_blank\">SPOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419709-mkm-spotifys-valuation-triple-spotplus-1_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MKM: Spotify&#39;s valuation could triple; SPOT +1.6%</a></h4><ul><li>MKM Partners suggests Spotify's (NYSE:<a href='https://seekingalpha.com/symbol/SPOT' title='Spotify'>SPOT</a>) market value could triple by 2022 with the stock trading at an attractive valuation following the recent pullback.</li><li>The firm has Spotify at a Buy rating and $200 target.</li><li>Source: Briefing.com.</li><li>Spotify shares are<font color=\"green\"> up 1.6%</font> premarket to $114.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419709\" data-linked=\"MKM: Spotify&#39;s valuation could triple; SPOT +1.6%\" data-tweet=\"$SPOT - MKM: Spotify&#39;s valuation could triple; SPOT +1.6% https://seekingalpha.com/news/3419709-mkm-spotifys-valuation-triple-spotplus-1_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3419709-mkm-spotifys-valuation-triple-spotplus-1_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419702\" data-ts=\"1546263103\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419702-height-capital-markets-defends-pg-and-e\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Height Capital Markets defends PG&amp;E</a></h4><ul> <li>Height Capital Markets updates on the developments with Pacific Gas &amp; Electric (NYSE:<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a>) and the California wildfires charges.</li> <li>The firm thinks California Attorney General Xavier Becerra took a milder stance than some of the media headlines on potential murder charges are indicating this morning.</li> <li>Height's take on the California AG: \"He emphasized that his office offered no opinion regarding PCG\u2019s criminal negligence or recklessness - only a summary of the charges they would face if found criminally culpable. With the AG\u2019s brief out of the way, we are looking towards 2019 for the release of the much-anticipated Tubbs fire report from CalFire.\"</li><li>Last week, Citi defended PG&amp;E by noting that structural changes forced on the company could lower future risk.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3419664-pg-and-e-may-face-charges-california-wildfires\" target=\"_blank\">PG&amp;E may face charges in California wildfires</a> (Dec. 31)</li> <li>PCG <font color=\"red\">-4.35%</font> premarket to $22.85.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3419702\" data-linked=\"Height Capital Markets defends PG&amp;E\" data-tweet=\"$PCG - Height Capital Markets defends PG&amp;E https://seekingalpha.com/news/3419702-height-capital-markets-defends-pg-and-e?source=tweet\" data-url=\"https://seekingalpha.com/news/3419702-height-capital-markets-defends-pg-and-e\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419701\" data-ts=\"1546262943\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IIVI\" target=\"_blank\">IIVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419701-northland-steps-to-outperform-on-ii-vi\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Northland steps to Outperform on II-VI</a></h4><ul><li>Brokerage service Northland Securities upgrades II-VI (NASDAQ:<a href='https://seekingalpha.com/symbol/IIVI' title='II-VI Incorporated'>IIVI</a>) from Market Perform to Outperform and raises the target by a dollar to $40, a 26% upside.</li><li>Source: Bloomberg First Word.</li><li>In November, II-VI <a href=\"https://seekingalpha.com/news/3408263-finisar-ii-vi-analysts-react-buyout-deal\" target=\"_blank\">announced plans</a> to acquire Finisar at a 38% premium for a total deal value of $3.2B.</li><li>IIVI shares are <font color=\"green\">up 3%</font> premarket to $32.76.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419701\" data-linked=\"Northland steps to Outperform on II-VI\" data-tweet=\"$IIVI - Northland steps to Outperform on II-VI https://seekingalpha.com/news/3419701-northland-steps-to-outperform-on-ii-vi?source=tweet\" data-url=\"https://seekingalpha.com/news/3419701-northland-steps-to-outperform-on-ii-vi\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419694\" data-ts=\"1546261866\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CWH\" target=\"_blank\">CWH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419694-camping-worldminus-4-after-key-exec-departs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Camping World -4% after key exec departs</a></h4><ul> <li>Shares of Camping World (NYSE:<a href='https://seekingalpha.com/symbol/CWH' title='Camping World Holdings'>CWH</a>) break lower in early action after the company discloses that Roger Nuttall resigned from his position as president.</li><li>No reason for Nuttall's departure was cited in the filing by Camping World.</li> <li><a href=\"https://seekingalpha.com/filing/4284327\" target=\"_blank\">SEC Form 8-K</a></li> <li>CWH <font color=\"red\">-4.43%</font> premarket to $11.85 vs. a 52-week trading range of $11.01 to $46.46.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3419694\" data-linked=\"Camping World -4% after key exec departs\" data-tweet=\"$CWH - Camping World -4% after key exec departs https://seekingalpha.com/news/3419694-camping-worldminus-4-after-key-exec-departs?source=tweet\" data-url=\"https://seekingalpha.com/news/3419694-camping-worldminus-4-after-key-exec-departs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419692\" data-ts=\"1546261484\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APHA\" target=\"_blank\">APHA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419692-aphria-down-7-premarket-on-questions-green-growth-bid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aphria down 7% premarket on questions with Green Growth bid</a></h4><ul><li>Aphria (NYSE:<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a>) slips <font color=\"red\">7%</font> premarket on modest volume on the heels of a <a href=\"https://www.bloomberg.com/news/articles/2018-12-31/green-growth-s-ceo-dismisses-doubts-about-bid-for-aphria-q-a\" target=\"_blank\">Bloomberg interview</a> with Green Growth Brands CEO Peter Horvath about certain aspects of its all-stock $2.1B bid for the pot producer, a deal that short seller Hindenburg Research calls \"non-credible.\"</li><li>Green Growth's second-largest shareholder is GA Opportunities Corp., a fund backed by Aphria and advised by CEO Vic Neufeld. Mr. Horvath says \"normally we don\u2019t ask who\u2019s behind the money because normally the answer is very complicated.\"</li><li>Green Growth's largest shareholder, the Schottenstein family, was involved with Aphria about a year ago. Mr. Horvath says he is unaware if they own any Aphria stock.</li><li>Green Growth currently owns one retail store and has an option to buy another in Nevada. Mr. Horvath says his firm will have 300 mall kiosks by the \"end of the year\" (2019?).</li><li>Previously: <a href=\"https://seekingalpha.com/news/3419505-aphria-says-green-growths-proposal-undervalues-shares\" target=\"_blank\">Aphria says Green Growth's proposal undervalues its shares</a> (Dec. 28)</li></ul><div class=\"tiny-share-widget\" data-id=\"3419692\" data-linked=\"Aphria down 7% premarket on questions with Green Growth bid\" data-tweet=\"$APHA - Aphria down 7% premarket on questions with Green Growth bid https://seekingalpha.com/news/3419692-aphria-down-7-premarket-on-questions-green-growth-bid?source=tweet\" data-url=\"https://seekingalpha.com/news/3419692-aphria-down-7-premarket-on-questions-green-growth-bid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419685\" data-ts=\"1546260047\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRY\" target=\"_blank\">TLRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419685-pot-stocks-poised-to-add-to-fridays-up-moves\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pot stocks poised to add to Friday&#39;s up moves</a></h4><ul><li>Tilray (NASDAQ:<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a>), Cronos Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a>) and Canopy Growth (NYSE:<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a>) are up <font color=\"green\">2%</font>, <font color=\"green\">3% </font>and <font color=\"green\">2%</font>, respectively, premarket, all on light volume.</li><li>All three moved up modestly at the end of last week.</li><li>Selected tickers that may see increased buying this week: <p><a href='https://seekingalpha.com/symbol/MJNA' title='Medical Marijuana, Inc.'>OTCPK:MJNA</a>, <a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a>, <a href='https://seekingalpha.com/symbol/GWPH' title='GW Pharmaceuticals plc'>GWPH</a>, <a href='https://seekingalpha.com/symbol/PHOT' title='Growlife Inc.'>OTCQB:PHOT</a>, <a href='https://seekingalpha.com/symbol/CBIS' title='Cannabis Science, Inc.'>OTCPK:CBIS</a>, <a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a>, <a href='https://seekingalpha.com/symbol/TRTC' title='Terra Tech Corp.'>OTCQX:TRTC</a>, <a href='https://seekingalpha.com/symbol/CANN' title='General Cannabis Corp.'>OTCQX:CANN</a>, <a href='https://seekingalpha.com/symbol/ERBB' title='American Green, Inc.'>OTCPK:ERBB</a>, <a href='https://seekingalpha.com/symbol/GRNH' title='GreenGro Technologies, Inc.'>OTCPK:GRNH</a>, <a href='https://seekingalpha.com/symbol/PMCB' title='PharmaCyte Biotech, Inc.'>OTCQB:PMCB</a>, <a href='https://seekingalpha.com/symbol/CVSI' title='CV Sciences, Inc.'>OTCQB:CVSI</a>, <a href='https://seekingalpha.com/symbol/FITX' title='Creative Edge Nutrition, Inc.'>OTC:FITX</a>, <a href='https://seekingalpha.com/symbol/MJ' title='ETFMG Alternative Harvest ETF'>MJ</a>, <a href='https://seekingalpha.com/symbol/HEMP' title='Hemp, Inc.'>OTCPK:HEMP</a>, <a href='https://seekingalpha.com/symbol/CBDS' title='Cannabis Sativa, Inc.'>OTCQB:CBDS</a>, <a href='https://seekingalpha.com/symbol/BLOZF' title='Cannabix Technologies Inc.'>OTCPK:BLOZF</a>, <a href='https://seekingalpha.com/symbol/KSHB' title='KushCo Holdings, Inc.'>OTCQB:KSHB</a>, <a href='https://seekingalpha.com/symbol/MSRT' title='MassRoots, Inc.'>OTCQB:MSRT</a>, <a href='https://seekingalpha.com/symbol/SPRWF' title='Supreme Cannabis Co Inc.'>OTCQX:SPRWF</a>, <a href='https://seekingalpha.com/symbol/AGTK' title='Agritek Holdings, Inc.'>OTCPK:AGTK</a>, <a href='https://seekingalpha.com/symbol/AMMJ' title='American Cannabis Company, Inc.'>OTCPK:AMMJ</a>, <a href='https://seekingalpha.com/symbol/VAPE' title='Vape Holdings, Inc.'>OTCPK:VAPE</a>, HYYDF, <a href='https://seekingalpha.com/symbol/GBLX' title='GB Sciences, Inc.'>OTCQB:GBLX</a>, <a href='https://seekingalpha.com/symbol/AERO' title='Aero Grow International, Inc.'>OTCQB:AERO</a>, <a href='https://seekingalpha.com/symbol/MCOA' title='Marijuana Company of America, Inc.'>OTCQB:MCOA</a>, <a href='https://seekingalpha.com/symbol/HMLSF' title='Horizons Marijuana Life Sciences Index ETF'>OTC:HMLSF</a>, <a href='https://seekingalpha.com/symbol/CNAB' title='United Cannabis Corp.'>OTCQB:CNAB</a>, <a href='https://seekingalpha.com/symbol/FSPM' title='Fusion Pharm, Inc.'>OTC:FSPM</a>, <a href='https://seekingalpha.com/symbol/EAPH' title='Easton Pharmaceuticals, Inc.'>OTCPK:EAPH</a>, <a href='https://seekingalpha.com/symbol/SRNA' title='Surna Inc.'>OTCQB:SRNA</a>, <a href='https://seekingalpha.com/symbol/RMHB' title='Rocky Mountain High Brands, Inc.'>OTCQB:RMHB</a>, <a href='https://seekingalpha.com/symbol/PLPL' title='Plandai Biotechnology, Inc.'>OTCPK:PLPL</a>, <a href='https://seekingalpha.com/symbol/MNTR' title='Mentor Capital, Inc.'>OTCQX:MNTR</a>, <a href='https://seekingalpha.com/symbol/EDXC' title='ENDEXX Corp.'>OTCPK:EDXC</a>, <a href='https://seekingalpha.com/symbol/THCBF' title='THC Biomed International Ltd.'>OTCQX:THCBF</a>, <a href='https://seekingalpha.com/symbol/FSPM' title='Fusion Pharm, Inc.'>OTC:FSPM</a>, <a href='https://seekingalpha.com/symbol/EAPH' title='Easton Pharmaceuticals, Inc.'>OTCPK:EAPH</a>, <a href='https://seekingalpha.com/symbol/SRNA' title='Surna Inc.'>OTCQB:SRNA</a>, <a href='https://seekingalpha.com/symbol/RMHB' title='Rocky Mountain High Brands, Inc.'>OTCQB:RMHB</a>, <a href='https://seekingalpha.com/symbol/PLPL' title='Plandai Biotechnology, Inc.'>OTCPK:PLPL</a>, <a href='https://seekingalpha.com/symbol/MNTR' title='Mentor Capital, Inc.'>OTCQX:MNTR</a>, <a href='https://seekingalpha.com/symbol/EDXC' title='ENDEXX Corp.'>OTCPK:EDXC</a>, <a href='https://seekingalpha.com/symbol/THCBF' title='THC Biomed International Ltd.'>OTCQX:THCBF</a>, <a href='https://seekingalpha.com/symbol/KAYS' title='Kaya Holdings, Inc.'>OTCQB:KAYS</a>, <a href='https://seekingalpha.com/symbol/ENRT' title='Enertopia Corp'>OTCQB:ENRT</a>, <a href='https://seekingalpha.com/symbol/ENDO' title='Endocan CorporationA'>OTCPK:ENDO</a>, <a href='https://seekingalpha.com/symbol/NTRR' title='Neutra Corp.'>OTCQB:NTRR</a>, <a href='https://seekingalpha.com/symbol/REFG' title='Medical Cannabis Payment Solutions'>OTCPK:REFG</a></p></li></ul><div class=\"tiny-share-widget\" data-id=\"3419685\" data-linked=\"Pot stocks poised to add to Friday&#39;s up moves\" data-tweet=\"$TLRY $TLRY $CRON - Pot stocks poised to add to Friday&#39;s up moves https://seekingalpha.com/news/3419685-pot-stocks-poised-to-add-to-fridays-up-moves?source=tweet\" data-url=\"https://seekingalpha.com/news/3419685-pot-stocks-poised-to-add-to-fridays-up-moves\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>74&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419675\" data-ts=\"1546258050\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBOT\" target=\"_blank\">MBOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419675-microbot-medical-files-for-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microbot Medical files for equity offering</a></h4><ul><li>Microbot Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/883975/000149315218018093/forms-1a.htm\" target=\"_blank\">preliminary prospectus</a> for an offering of up to ~6M Units, each consisting of one common share and one warrant to purchase one share of common at an assumed exercise price of $1.66.</li><li>The proposed price per Unit is also $1.66.</li><li>Friday's close was $1.80.</li></ul><div class=\"tiny-share-widget\" data-id=\"3419675\" data-linked=\"Microbot Medical files for equity offering\" data-tweet=\"$MBOT - Microbot Medical files for equity offering https://seekingalpha.com/news/3419675-microbot-medical-files-for-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3419675-microbot-medical-files-for-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419666\" data-ts=\"1546257229\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419666-canada-gooseplus-6-after-beijing-store-dazzles\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canada Goose +6% after Beijing store dazzles</a></h4><ul> <li>Canada Goose's first store in China outside of Hong Kong is <a href=\"https://www.reuters.com/article/us-canada-goose-china/canada-gooses-first-china-store-draws-eager-crowds-despite-diplomatic-headwinds-idUSKCN1OU0FG?feedType=RSS&amp;feedName=businessNews\" target=\"_blank\">drawing</a> huge crowds since opening on Friday, according to local reports.</li> <li>The launch of the Beijing store was delayed by about two weeks due to construction work, not political considerations as some have speculated.</li><li>Shares of Canada Goose are <font color=\"green\">up 5.91%</font> in premarket trading to $44.25.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3419666\" data-linked=\"Canada Goose +6% after Beijing store dazzles\" data-tweet=\"Canada Goose +6% after Beijing store dazzles https://seekingalpha.com/news/3419666-canada-gooseplus-6-after-beijing-store-dazzles?source=tweet\" data-url=\"https://seekingalpha.com/news/3419666-canada-gooseplus-6-after-beijing-store-dazzles\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3419664\" data-ts=\"1546255583\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3419664-pg-and-e-may-face-charges-in-california-wildfires\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E may face charges in California wildfires</a></h4><ul><li>California\u2019s attorney general has <a href=\"https://www.cnbc.com/2018/12/31/pge-could-face-charges-in-california-wildfires-.html\" target=\"_blank\">told</a> a federal judge it's possible that Pacific Gas &amp; Electric (NYSE:<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a>) could face charges up to murder if investigators find reckless operation of power equipment caused any deadly wildfires in the past two years.</li><li>The state\u2019s largest power utility has until today to file its response.</li><li>According to the<em> Sacramento Bee</em>, the brief is purely advisory, and any criminal charges would most likely be filed by county district attorneys, not the state.</li><li>PCG <font color=\"red\">-3.7%</font> premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3419664\" data-linked=\"PG&amp;E may face charges in California wildfires\" data-tweet=\"$PCG - PG&amp;E may face charges in California wildfires https://seekingalpha.com/news/3419664-pg-and-e-may-face-charges-in-california-wildfires?source=tweet\" data-url=\"https://seekingalpha.com/news/3419664-pg-and-e-may-face-charges-in-california-wildfires\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":47,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}